PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

NCT04305405 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Uncontrolled Asthma

Interventions

DRUG: Benralizumab

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]